Edwards Lifesciences Corp - Company Profile
Powered by 
All the data and insights you need on Edwards Lifesciences Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Edwards Lifesciences Corp Strategy Report
- Understand Edwards Lifesciences Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that is engaged in the development, manufacturing and marketing of devices for structural heart disease, critical care and surgical monitoring. The company’s products include surgical valve repair devices, surgical valve replacement, hemodynamic monitoring devices, transcatheter heart valves, pressure monitoring devices, and related instruments and accessories. Its products find application in various therapies, including transcatheter aortic valve replacement (TAVR), blood conservation, infection control, enhanced surgical recovery, and for the management of clotting, hypotension and sepsis. The company markets products through direct sales force and also a network of independent distributors in North America, Europe and Asia-Pacific, among others. Edwards Lifesciences is headquartered in Irvine, California, the US.
Headquarters
United States of America
Address
One Edwards Way, Irvine, California, 92614
Website
www.edwards.com
Telephone
1 949 2502500
No of Employees
19,800
Industry
Medical Equipment
Ticker Symbol & Exchange
EW (NYSE)
Revenue (2022)
$6.0B
11.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-7.9%
(2022 vs 2021)
Market Cap*
$53.7B
Net Profit Margin (2022)
XYZ
-17.4%
(2022 vs 2021)
* As of and is in US$
Edwards Lifesciences Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Surgical Valve Repair: | AnastaFlo |
| Tricuspid Valve Repair | AVA 3Xi/HF |
| Mitral Valve Repair | Carpentier |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Regulatory Approval | In February, the company secured approval from the US Food and Drug Administration for the EVOQUE tricuspid valve replacement system. |
| 2022 | New Product Approvals | In March, the company's Mitris Resilia valve received the US FDA approval for mitral replacement surgeries |
| 2021 | Contracts/Agreements | In April, the company entered into a partnership with Providence, Cities of Irvine, Santa Ana, Costa Mesa and Tustin to open two free mass COVID-19 vaccination clinics. |
Competitor Comparison
| Key Parameters | Edwards Lifesciences Corp | Abbott Laboratories | Medtronic Plc | Boston Scientific Corp | ICU Medical Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Ireland | United States of America | United States of America |
| City | Irvine | Abbott Park | Dublin | Marlborough | San Clemente |
| State/Province | California | Illinois | - | Massachusetts | California |
| No. of Employees | 19,800 | 114,000 | 95,000 | 48,000 | 14,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Bernard Zovighian | Chief Executive Officer; Director | Executive Board | 2023 | 55 |
| Scott B. Ullem | Corporate Vice President; Chief Financial Officer | Senior Management | 2014 | 56 |
| Todd J. Brinton, M.D. | Chief Scientific Officer; Corporate Vice President - Advanced Technology | Senior Management | 2019 | - |
| Arnold A. Pinkston | Corporate Vice President; General Counsel | Senior Management | 2019 | - |
| Ben Cheong | General Manager - China operations; Senior Vice President | Senior Management | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward